For citations:
Akatova EV, Bakhareva YS, Bugrova OV, Vinogradova IB, Gerasimova EV, Drevina YE, Ershova OB, Zonova EV, Ivanova YI, Ilivanova EP, Kostik MM, Krechikova DG, Kusevich DA, Maslyansky AL, Meshkov AD, Mosesova NS, Nagornova KA, Nosovich DV, Polyakova SA, Popova TA, Smolyarchuk EA, Sorotskaya VN, Shvarts YG, Shilova LN, Shostak MS, Yunonin IY, Akhtyamova-Givirovskaya NE, Khamitov RA, Markova OA, Zagoruiko EI, Zuev EV. Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2024;18(6):36-45. (In Russ.) https://doi.org/10.14412/1996-7012-2024-6-36-45
Email this article 